Tuesday, April 19, 2016

BRIEF-Synergy pharmaceuticals says FDA set Jan 29, 2017 as PDUFA for constipation drug

* Synergy pharmaceuticals announces acceptance of new drug

application for plecanatide, a novel uroguanylin analog, in

chronic idiopathic constipation

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)